GE HealthCare Files 8-K on Feb 15 Event

TL;DR

**GE HealthCare just filed an 8-K for a Feb 15 event, keeping the market updated on corporate info.**

AI Summary

GE HealthCare Technologies Inc. filed an 8-K on February 16, 2024, reporting an event that occurred on February 15, 2024. The filing indicates that the company, incorporated in Delaware with IRS Employer Identification No. 88-2515116, is located at 500 W. Monroe Street, Chicago, IL 60661, and its telephone number is (833) 735-1139. This 8-K is a 'Current Report' filed pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934.

Why It Matters

This filing provides updated public information about GE HealthCare Technologies Inc., ensuring transparency and compliance with SEC regulations for investors and the market.

Risk Assessment

Risk Level: low — This 8-K is a routine filing for 'Other Events' and 'Financial Statements and Exhibits,' indicating standard corporate disclosure without immediate red flags.

Key Players & Entities

• GE HealthCare Technologies Inc. (company) — registrant
• February 15, 2024 (date) — date of earliest event reported
• February 16, 2024 (date) — filing date
• Delaware (company) — state of incorporation
• 88-2515116 (company) — IRS Employer Identification No.
• 500 W. Monroe Street, Chicago, IL 60661 (company) — principal executive offices address
• (833) 735-1139 (company) — registrant's telephone number

FAQ

Key Financial Figures

• $0.01 — ich registered Common stock, par value $0.01 per share GEHC The Nasdaq Stock Mar
• $82.25 — Shares") at a public offering price of $82.25 per share ($80.605 per share, net of un
• $80.605 — lic offering price of $82.25 per share ($80.605 per share, net of underwriting discount

Filing Documents

• d787884d8k.htm (8-K) — 29KB
• d787884dex11.htm (EX-1.1) — 151KB
• d787884dex991.htm (EX-99.1) — 10KB
• d787884dex992.htm (EX-99.2) — 11KB
• 0001193125-24-038569.txt ( ) — 366KB
• gehc-20240215.xsd (EX-101.SCH) — 3KB
• gehc-20240215_lab.xml (EX-101.LAB) — 17KB
• gehc-20240215_pre.xml (EX-101.PRE) — 11KB
• d787884d8k_htm.xml (XML) — 3KB

Financial Statements and Exhibits

Financial Statements and Exhibits. (d)Exhibits 1.1 Underwriting Agreement, dated February 15, 2024, among GE HealthCare Technologies Inc., General Electric Company, Morgan Stanley & Co. LLC, as selling stockholder, and Morgan Stanley & Co. LLC and BofA Securities, Inc., as representatives of the several underwriters named therein. 99.1 Press Release of GE HealthCare Technologies Inc., dated February 15, 2024. 99.2 Press Release of GE HealthCare Technologies Inc., dated February 16, 2024. 104 The cover page of this Current Report on Form 8-K, formatted in Inline XBRL

Forward Looking Statements

Forward Looking Statements This Current Report on Form 8-K and Exhibits 99.1 and 99.2 hereto contain "forward-looking statements," including statements regarding the Offering. These forward-looking statements might be identified by words, and variations of words, such as "will," "expect," "may," "would," "could," "plan," and similar expressions. These forward-looking statements reflect management's current plans, estimates and expectations and are inherently uncertain. The inclusion of any forward-looking information in this document should not be regarded as a representation that the future plans, estimates or expectations contemplated will be achieved. These forward-looking statements involve risks and uncertainties, many of which are beyond the Company's control. Factors that could cause actual results to differ materially from those described in the Company's forward-looking statements include, but are not limited to, risks and uncertainties associated with market conditions and the satisfaction of customary closing conditions related to the Offering, and the other factors detailed in the Company's Registration Statement on Form S-3 filed with the U.S. Securities and Exchange Commission (the "SEC") on February 15, 2024, as well as other risks discussed in the Company's filings with the SEC. Please also see the "Risk Factors" section of the Company's Form 10-K filed with the SEC and any updates or amendments it makes in future filings. There may be other factors not presently known to the Company or which it currently considers to be immaterial that could cause the Company's actual results to differ materially from those projected in any forward-looking statements the Company makes. The Company does not undertake any obligation to update or revise its forward-looking statements except as required by applicable law or regulation.

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: February 16, 2024 GE HealthCare Technologies Inc. (Registrant) /s/ Frank R. Jimenez Frank R. Jimenez, General Counsel and Corporate Secretary (authorized signatory)

View Full Filing

View this 8-K filing on SEC EDGAR